Related Experiment Video
Updated: Aug 7, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
David A Price1, Duncan Armour, Marcel de Groot
1Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, UK. david.a.price@pfizer.com
Abstract:
The discovery of maraviroc 17 is described with particular reference to the generation of high selectivity over affinity for the HERG potassium channel. This was achieved through the use of a high throughput binding assay for the HERG channel that is known to show an excellent correlation with functional effects.
More Related Videos
Related Concept Videos
Inhibitors Of Virion Release
Subviral Agents
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Treatment Resistent Cancers

